Real-time enrollment status for this rsv infection clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:17 PM UTC
| NCT Number | NCT06843317 |
| Recruiting Status | Recruiting |
| Condition | RSV Infection |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Clover Biopharmaceuticals USA, LLC |
| Last Updated on CT.gov | May 14, 2025 (May 14, 2025) |
As of July 13, 2026: Clinical trial NCT06843317 is currently recruiting participants. This clinical trial study for rsv infection is actively seeking new participants at 5 locations across the United States. The study is sponsored by Clover Biopharmaceuticals USA, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06843317 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06843317 was last updated May 14, 2025 (May 14, 2025). HelloStudys verifies this status automatically.